Browsing Tag

Cybrexa

Cybrexa Therapeutics to Present Virtually at H.C. Wainwright 23rd Annual Global Investment…

Jason Junior Sep 10, 2021

NEW HAVEN, Conn., Sept. 10, 2021 (GLOBE NEWSWIRE) -- Cybrexa Therapeutics, an oncology-focused biotechnology company developing a new class of therapeutics through its alphalex™ Peptide Drug Conjugate (PDC) tumor targeting platform,…

Health

Cybrexa Therapeutics to Present at BTIG Virtual Biotechnology Conference 2021

Jason Junior Aug 5, 2021

NEW HAVEN, Conn., Aug. 04, 2021 (GLOBE NEWSWIRE) -- Cybrexa Therapeutics, an oncology-focused biotechnology company developing a new class of therapeutics through its alphalex™ Peptide Drug Conjugate (PDC) tumor targeting platform,…

Health

Cybrexa Therapeutics Announces Publication of Peer-Reviewed Article in NAR Cancer

Jason Junior Jun 9, 2021

NEW HAVEN, Conn., June 08, 2021 (GLOBE NEWSWIRE) -- Cybrexa Therapeutics, an oncology-focused biotechnology company developing a new class of therapeutics through its alphalex™ Peptide Drug Conjugate (PDC) tumor targeting platform, today…